Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs

Authors:

Abstract
In this study, the immunoadjuvant effects of recombinant porcine interferon alpha (rPoIFN α ) on the killed virus vaccine (KV) of porcine reproductive and respiratory syndrome virus (PRRSV) in pigs were investigated. The experimental pigs were divided into six groups, including normal control group, rPoIFN α control group, PRRSV KV control group, KV+40,000 U rPoIFN α immunization group, KV+400,000 U rPoIFN α immunization group, and KV+4,000,000 U rPoIFN α immunization group. The experimental pigs were boosted immunized on the 28th day after the initial immunization, and the heparinized blood and serum samples were collected at different time points of these two immunizations to detect and evaluate the immune responses of pigs after immunization by ELISA assay, neutralization assay, flow cytometry, and so on. The results showed that the proportion of the levels of PRRSV-specific antibodies, neutralizing antibodies, stimulation index, IL-4, IFN-γ, and lymphocytes within the groups immunized with KV+rPoIFN α were significantly higher than that group immunized with KV alone. The humoral and cellular immune responses in pigs were markedly enhanced by rPoIFN α after the coadministration with KV vaccine. Therefore, we tentatively think that rPoIFN α is a potential immune promoter with prospects for future applications in the pig industry.

This publication has 38 references indexed in Scilit: